You are here: Industry Insights > patent

News List

Trovagene Announces Patent for Combination of Onvansertib with Anti-Androgen Drugs americanpharmaceuticalreview
January 24, 2019
Trovagene announced the issuance of a new patent (10,155,006), entitled Combination Therapies and Methods of Use Thereof for Treating Cancer....
Mylan says Sanofi loses Lantus insulin patent claims expressbpd
December 14, 2018
Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and paediatric patients with type 1 diabetes to control high blood sugar
Pfizer loses Lyrica patent case in UK Supreme Court pharmaceutical-technology
November 16, 2018
The UK Supreme Court has ruled against Pfizer in a long running legal case involving a second medical use patent for its Lyrica (pregabalin) drug.
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica fiercepharma
November 15, 2018
Pfizer has come up short in a long-running patent battle in the U.K. over its blockbuster Lyrica, and the loss could come with a significant financial hit for the drugmaker.
AbbVie announces global patent license with Momenta biospectrum
November 08, 2018
Momenta's U.S. license will begin on November 20, 2023, and will not be accelerated by the entry of companies who have already taken a license.
Biosimilars market to increase to $61.47 billion europeanpharmaceuticalreview
September 26, 2018
A report has suggested that the biosimilars market growth will increase at a CAGR of 34.2 percent over the course of the period analysed…
SpinalCyte Announces New U.S. Patent americanpharmaceuticalreview
August 29, 2018
SpinalCyte announced issuance of U.S. Patent No. 10,052,410, “Methods and Compositions For Repair Of Cartilage Using An In Vivo Bioreactor.”
Soligenix Receives Patent for Improved Production of Synthetic Hypericin americanpharmaceuticalreview
August 24, 2018
Soligenix announced the United States Patent Office (USPTO) has granted the patent titled "Systems and Methods for Producing Synthetic Hypericin.”
Merck receives Australian CRISPR Nickase Patent biospectrumasia
August 17, 2018
In addition to allowing a patent application on paired nickases, the Australian Patent Office recently announced the formal grant of Merck's 2017 CRISPR integration patent, following withdrawal of four independent, anonymously filed oppositions.
RXi Receives Patent from USPTO americanpharmaceuticalreview
May 18, 2018
RXi Pharmaceuticals has been granted a patent from the United States Patent and Trademark Office (USPTO) for the methods of use of sd-rxRNAs targeting Connective Tissue Growth Factor (CTGF) for the treatment or prevention of fibrotic disorders,

Previous page 1 2 3 4 5 6 Next page